newsfilter
← Latest News
GlobeNewswire·

Zealand Pharma – Notification of holding of treasury shares

  • Zealand Pharma announced its holding of 3,597,842 treasury shares as of 21 August 2026 pursuant to Section 31 of the Danish Capital Markets Act.
  • These treasury shares represent 5.03% of the total share capital & 5.03% of the total voting rights.
  • In accordance with Section 85 of the Danish Companies Act, the company cannot exercise voting rights attached to its treasury shares.
  • Zealand Pharma is a biotechnology company focused on obesity & metabolic health with operations in Copenhagen & Boston.
  • The company has over 25 years of peptide R&D expertise & utilizes AI/ML approaches in its proprietary data platform.
  • More than 10 drug candidates invented by the company have entered clinical development, with two products on the market & three in late-stage development.